Activation of Raf-1 by interferon γ and oncostatin M requires expression of the Stat1 transcription factor

被引:32
作者
Stancato, LF
Yu, CR
Petricoin, EF
Larner, AC
机构
[1] NCI, Mol & Cellular Biol Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Expt Immunol Lab, NIH, Frederick, MD 21701 USA
[3] Ctr Biol Evaluat & Res, Div Cytokine Biol, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.273.30.18701
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A primary signaling cascade responsible for the ex pression of cytokine-stimulated immediate early genes involves the activation of the Jak/Stat pathway. In addition to being tyrosine-phosphorylated, several signal transducers and activators of transcription (Stats), including Stat1 alpha, Stat3, and Stat4, are phosphorylated on a conserved serine residue, which is a consensus phosphorylation site for mitogen-activated protein kinases (MAPKs), Serine phosphorylation of Stat1 alpha is required for maximal transcriptional activation of early response genes by interferon gamma (IFN gamma) as well as the antiviral and antigrowth actions of this cytokine. Incubation of cells with either IFN gamma or oncostatin M (OSM) activates Raf-1, a serine/threonine kinase responsible for the ultimate activation of p42 MAPK. To examine whether any of the signaling components that are required for activation of the Jak/Stat pathway are also necessary for activation of Raf-1 by IFNs and OSM, we examined activation of Raf-1 in cell lines that are deficient in either Stat1 alpha or Stat2. Unexpectedly, incubation of Stat1-deficient, but not Stat2-deficient cells with IFN gamma or OSM for 5 min displayed no increase in Raf-1 activity. In peripheral blood lymphocytes Raf-1 was associated with Stat1, and this interaction was disrupted after incubation of cells with IFN gamma, Stat1-negative cells reconstituted with either Stat1 alpha or Stat1 alpha with a point mutation in the site where it is serine-phosphorylated displayed normal activation of Raf-1 by IFN gamma and OSM, However, activation of Raf-1 was not observed in lines that expressed Stat1 alpha containing a mutation in its tyrosine phosphorylation site or in its SH2 domain. These results provide the first example of a novel role of Stat1 alpha not as a transcription factor, but as a protein which may function to scaffold signaling components required for activation of the distinct Raf/MEK/MAPK signaling cascade.
引用
收藏
页码:18701 / 18704
页数:4
相关论文
共 20 条
[1]   Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma [J].
Bromberg, JF ;
Horvath, CM ;
Wen, ZL ;
Schreiber, RD ;
Darnell, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7673-7678
[2]  
BUSCHER D, 1995, MOL CELL BIOL, V15, P466
[3]   REQUIREMENT FOR MAP KINASE (ERK2) ACTIVITY IN INTERFERON-ALPHA-STIMULATED AND INTERFERON-BETA-STIMULATED GENE-EXPRESSION THROUGH STAT PROTEINS [J].
DAVID, M ;
PETRICOIN, E ;
BENJAMIN, C ;
PINE, R ;
WEBER, MJ ;
LARNER, AC .
SCIENCE, 1995, 269 (5231) :1721-1723
[4]  
DAVID M, 1995, MOL CELL BIOL, V15, P7050
[5]   The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression [J].
David, M ;
Zhou, GC ;
Pine, R ;
Dixon, JE ;
Larner, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) :15862-15865
[6]  
DENT P, 1995, MOL CELL BIOL, V15, P4125
[7]   The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein [J].
Horvath, CM ;
Darnell, JE .
JOURNAL OF VIROLOGY, 1996, 70 (01) :647-650
[8]  
IGARASHI K, 1994, J BIOL CHEM, V269, P14333
[9]   Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases [J].
Kumar, A ;
Commane, M ;
Flickinger, TW ;
Horvath, CM ;
Stark, GR .
SCIENCE, 1997, 278 (5343) :1630-1632
[10]   PROTEIN-TYROSINE PHOSPHORYLATION AS A MECHANISM WHICH REGULATES CYTOKINE ACTIVATION OF EARLY RESPONSE GENES [J].
LARNER, AC ;
FINBLOOM, DS .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1995, 1266 (03) :278-287